There has been a lot of talk about drugs targeting both PD-1 and VEGF stealing the crown held by MSD's Keytruda in cancer immunotherapy. Now, the company has made a move to try to make sure it isn't ...
The CEO of Swiss pharmaceutical company Novartis said Saturday that it has enough stockpiles in the US to withstand any potential tariffs from President Trump, Reuters reported. Pharmaceuticals are ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback